When you read about Osborne Clarke on this site, we are either referring to our international organisation, Osborne Clarke Verein (OCV), or one of its member firms. OCV is a Swiss verein and doesn’t provide services to clients. The OCV member firms are all separate legal entities and have no authority to obligate or bind each other or OCV with regard to third parties. To find out more, click here.

Belgium

China

France

Germany

India

Italy

Poland

Singapore

Spain

Sweden

The Netherlands

UK

USA

News search

Osborne Clarke advises Amphista Therapeutics on its $53M Series B funding round

Osborne Clarke advises Science Creates Ventures on its first investment

Osborne Clarke advises the management team of Davies on investment from BC Partners to support global expansion and digital transformation

Osborne Clarke and Devonshires advise M&G on the launch of its new Shared Ownership Fund

Osborne Clarke advises In The Style Group plc on its successful £105 million AIM IPO

Osborne Clarke advises the shareholders of Fortius Group on its sale

Osborne Clarke advises BGF on its investment in Stark

Osborne Clarke advises Canaccord and Shore Capital on £22 million equity raise

Sign up for our newsletter

Legal Notice